N. Sumi

发表

Spontaneous neoplastic lesions in aged Sprague-Dawley rats.

M. Ueda, A. Ueda, M. Nakazawa, 2001, Experimental animals.

RECENT TOPICS ON THE MECHANISMS OF RODENT HEPATOCARCINOGENESIS

Tomoyuki Watanabe, T. Usui, T. Aoki, 1995 .

[Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in rats followed by 9-week recovery test].

T. Nishimori, K. Iwakura, N. Sumi, 1995, The Journal of toxicological sciences.

[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(2)--A teratogenicity study in rats by oral administration]

Y. Shindo, K. Yasuhira, N. Sumi, 1996 .

[Reproductive and developmental toxicity studies of montirelin hydrate (2)--Teratogenicity and postnatal study in rats by intravenous administration].

M. Watanabe, K. Yasuhira, N. Sumi, 1995, The Journal of toxicological sciences.

[Reproductive and developmental toxicity studies of montirelin hydrate (4)--Perinatal and postnatal study in rats by intravenous administration].

T. Nishimori, M. Watanabe, N. Sumi, 1995, The Journal of toxicological sciences.

Seventy-eight-week dietary carcinogenicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in mice.

R. Hatch, K. Regan, M. Nakazawa, 1997, The Journal of toxicological sciences.

Two-year dietary carcinogenicity study of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats.

R. Hatch, K. Regan, M. Nakazawa, 1997, The Journal of toxicological sciences.

[A photoallergenicity study of prulifloxacin (NM441) in guinea pigs].

T. Inoue, M. Ishihara, K. Kamata, 1996, The Journal of toxicological sciences.

[Mutagenicity studies of prulifloxacin (NM441) and the active metabolite (NM394)].

M. Ando, H. Tamura, Y. Shindo, 1996, The Journal of toxicological sciences.

Testicular Yolk Sac Carcinoma in an Aged Sprague-Dawley Rat

M. Ueda, A. Ueda, M. Nakazawa, 1998 .

[A 13-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats followed by a 5-week recovery test].

M. Yoshida, M. Nakazawa, T. Tawaratani, 1997, The Journal of toxicological sciences.

A case of muItiloculated, intracranial epidermoid cyst in a beagle dog

M. Nakazawa, T. Tawaratani, H. Uchimoto, 1991, Laboratory animals.

The incidence of spontaneous tumors of the central nervous system of wistar rats

D. Stavrou, N. Sumi, H. Frohberg, 1976, Archives of Toxicology.

Enhancement of the clastogenicity of N‐nitrosodialkylamines plus near‐ultraviolet irradiation by ethanol in Chinese hamster lung fibroblasts

H. Hayatsu, S. Arimoto, N. Sumi, 1997, Environmental and molecular mutagenesis.

Synergistic action of N-nitrosodialkylamines and near-UV in the induction of chromosome aberrations in Chinese hamster lung fibroblasts in vitro.

H. Hayatsu, S. Arimoto, N. Sumi, 1995, Mutation research.

The mechanism of lactitol (NS-4) in inducing adrenomedullary proliferative lesion in rats.

H. Tamura, M. Yoshida, K. Yoshikawa, 1995, The Journal of toxicological sciences.

[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(3)--A teratogenicity study in rabbits by oral administration].

Y. Shindo, M. Watanabe, K. Yasuhira, 1996, The Journal of toxicological sciences.

[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(1)--A fertility study in rats by oral administration].

Y. Shindo, M. Watanabe, K. Yasuhira, 1996, Journal of Toxicological Sciences.

[A 4-week intravenous toxicity study of the active metabolite (NM394) of prulifloxacin (NM441) in rats followed by a 4-week recovery test].

S. Yamazaki, M. Iketani, S. Ishida, 1996, The Journal of toxicological sciences.

[Single-dose toxicity studies of prulifloxacin (NM441) in mice, rats and dogs and the active metabolite (NM394) in rats].

M. Yoshida, Y. Shindo, K. Iwakura, 1996, The Journal of toxicological sciences.

[A 13-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 5-week recovery test].

M. Yoshida, Y. Shindo, T. Tawaratani, 1996, The Journal of toxicological sciences.

[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(4)--A perinatal and postnatal study in rats by oral administration].

T. Nishimori, Y. Shindo, M. Watanabe, 1996, The Journal of toxicological sciences.

[Renal toxicity of prulifloxacin (NM441) in rats].

K. Kakemi, Y. Shindo, T. Tawaratani, 1996, The Journal of toxicological sciences.

[Antigenicity studies of prulifloxacin (NM441)].

Y. Shindo, N. Sumi, T. Nakasuji, 1996, The Journal of toxicological sciences.

[Single and 4-week oral toxicity studies of prulifloxacin (NM441) in aged dogs].

Y. Shindo, T. Ihara, K. Nakama, 1996, The Journal of toxicological sciences.

TWO YEAR CARCINOGENICITY STUDY OF ETODOLAC, A NONSTEROIDAL ANTI-INFLAMMATORY AGENT, IN CHARLES RIVER CR-CD RATS

J. J. Pollock, N. Sumi, R. Hemm, 1991 .

[The mechanism of increased thyroidal function caused by (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, administration in rats].

K. Wakabayashi, H. Tamura, M. Yoshida, 1997, The Journal of toxicological sciences.

[Single-dose toxicity studies of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice, rats and dogs].

M. Yoshida, M. Nakazawa, K. Iwakura, 1997, The Journal of toxicological sciences.

[Intraperitoneal single-dose toxicity studies of active metabolite, optical isomers, hydrolysis products and bi-product of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence,

J. Kobayashi, K. Iwakura, N. Sumi, 1997, The Journal of toxicological sciences.

[Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].

H. Tamura, M. Watanabe, K. Iwakura, 1997, The Journal of toxicological sciences.

[Mutagenicity studies of montirelin hydrate (NS-3)].

H. Tamura, M. Watanabe, K. Iwakura, 1995, The Journal of toxicological sciences.

[Mutagenicity studies of lactitol (NS-4)].

H. Tamura, M. Watanabe, K. Iwakura, 1994, The Journal of toxicological sciences.